MUZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 8.548
EU - Europa 1.730
AS - Asia 622
SA - Sud America 78
AF - Africa 5
OC - Oceania 3
Totale 10.986
Nazione #
US - Stati Uniti d'America 8.536
IT - Italia 947
SG - Singapore 277
CN - Cina 185
DE - Germania 179
FR - Francia 125
UA - Ucraina 120
BR - Brasile 65
IE - Irlanda 62
NL - Olanda 55
HK - Hong Kong 54
SE - Svezia 53
RU - Federazione Russa 47
PL - Polonia 39
GB - Regno Unito 36
FI - Finlandia 27
KR - Corea 25
VN - Vietnam 24
CZ - Repubblica Ceca 21
IN - India 11
JP - Giappone 9
BD - Bangladesh 8
AR - Argentina 6
CA - Canada 6
ES - Italia 5
ID - Indonesia 5
MX - Messico 5
TR - Turchia 5
AU - Australia 3
CO - Colombia 3
UZ - Uzbekistan 3
AT - Austria 2
CH - Svizzera 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
ZA - Sudafrica 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
GD - Grenada 1
GE - Georgia 1
IR - Iran 1
KG - Kirghizistan 1
LT - Lituania 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
Totale 10.986
Città #
Woodbridge 2.643
Houston 2.106
Wilmington 1.937
Ann Arbor 244
Chandler 226
Fairfield 219
Singapore 155
Ashburn 140
Jacksonville 104
Rome 100
Seattle 83
New York 75
Beijing 73
Milan 70
Cambridge 65
Dublin 61
Hong Kong 53
Medford 51
Dallas 41
Kraków 30
Dearborn 28
Los Angeles 27
Santa Clara 27
Lawrence 24
The Dalles 22
Prague 21
Naples 19
Council Bluffs 18
Mülheim 18
Buffalo 14
Zhengzhou 14
Florence 13
Palo Alto 13
Turin 13
Falls Church 12
Guangzhou 12
Shanghai 12
Boardman 11
Catania 11
Menlo Park 11
Pisa 9
San Diego 9
Verona 9
Civitavecchia 8
Hefei 8
Ho Chi Minh City 8
Bari 7
Bologna 7
Moscow 7
Pioppi 7
São Paulo 7
University Park 7
Brescia 6
Columbus 6
London 6
Mountain View 6
Napoli 6
Pavia 6
Phoenix 5
Reggio Emilia 5
San Mateo 5
Calusco d'Adda 4
Jakarta 4
Nanjing 4
Novara 4
Nuremberg 4
Padova 4
Palermo 4
Redwood City 4
Saint Petersburg 4
Toronto 4
Treviso 4
Altopascio 3
Brasília 3
Cagliari 3
Chicago 3
Curitiba 3
Dong Ket 3
Ercolano 3
Ferrara 3
Fidenza 3
Hanoi 3
Helsinki 3
Jinan 3
Kunming 3
Lecce 3
Massa 3
Pordenone 3
Pune 3
Salt Lake City 3
San Jose 3
Sesto San Giovanni 3
Somma Lombardo 3
Tokyo 3
Affi 2
Anagni 2
Andretta 2
Angri 2
Apollosa 2
Assemini 2
Totale 9.082
Nome #
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I 1.456
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 498
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 469
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide 464
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 461
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 443
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells 441
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells 437
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. 431
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 424
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. 415
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. 413
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 410
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 407
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 403
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. 397
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant 393
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 391
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 391
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB 389
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. 383
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors 378
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. 355
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. 347
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 36
Totale 11.032
Categoria #
all - tutte 22.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021596 0 0 0 0 0 157 149 130 49 24 55 32
2021/2022296 9 29 25 13 5 32 6 8 45 36 6 82
2022/2023582 50 50 27 78 38 92 26 41 72 26 43 39
2023/2024449 43 22 38 44 30 87 36 25 18 22 32 52
2024/2025772 44 145 91 63 53 72 45 53 70 38 43 55
2025/2026501 127 47 139 61 83 44 0 0 0 0 0 0
Totale 11.032